logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Neuromuscular Blocker class drugs

    FiltersReset Filters
    5 results

    • botox

      (onabotulinumtoxinA)
      Allergan, Inc.
      Usage: BOTOX is indicated for treating adult overactive bladder, detrusor overactivity due to neurologic conditions, chronic migraine prophylaxis, spasticity, cervical dystonia, severe primary axillary hyperhidrosis, and blepharospasm or strabismus in patients 12 years and older. It's also approved for neurogenic detrusor overactivity in children aged 5 and older.

    • botox cosmetic

      (onabotulinumtoxinA)
      Allergan, Inc.
      Usage: BOTOX Cosmetic (onabotulinumtoxinA) is indicated for the temporary improvement of the appearance of moderate to severe glabellar lines, lateral canthal lines, forehead lines, and platysma bands in adult patients, all associated with specific muscle activities.

    • dysport

      (Botulinum Toxin Type A)
      Galderma Laboratories, L.P.
      Usage: DYSPORT is indicated for treating cervical dystonia in adults, improving the appearance of moderate to severe glabellar lines in adults under 65, and managing spasticity in patients aged 2 and older.

    • jeuveau

      (Prabotulinum Toxin Type A)
      Evolus, Inc.
      Usage: JEUVEAU is indicated for the temporary improvement of moderate to severe glabellar lines in adults, specifically those associated with the activity of the corrugator and/or procerus muscles.

    • xeomin

      (incobotulinumtoxinA)
      Merz North America, Inc.
      Usage: XEOMIN is indicated for treating chronic sialorrhea in patients aged 2 and older, upper limb spasticity in adults and pediatric patients aged 2-17 (excluding cerebral palsy), cervical dystonia, blepharospasm in adults, and for temporary improvement of upper facial lines in adults.